NO982181L - Type IX collagen og chimerer - Google Patents

Type IX collagen og chimerer

Info

Publication number
NO982181L
NO982181L NO982181A NO982181A NO982181L NO 982181 L NO982181 L NO 982181L NO 982181 A NO982181 A NO 982181A NO 982181 A NO982181 A NO 982181A NO 982181 L NO982181 L NO 982181L
Authority
NO
Norway
Prior art keywords
type
collagen
collagens
chimeras
new
Prior art date
Application number
NO982181A
Other languages
English (en)
Norwegian (no)
Other versions
NO982181D0 (no
Inventor
Eero Vuorio
George Martin
Thomas B Neff
Leena Ala-Kokko
Original Assignee
Fibrogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrogen Inc filed Critical Fibrogen Inc
Publication of NO982181D0 publication Critical patent/NO982181D0/no
Publication of NO982181L publication Critical patent/NO982181L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO982181A 1995-11-13 1998-05-13 Type IX collagen og chimerer NO982181L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US660895P 1995-11-13 1995-11-13
US74553996A 1996-11-12 1996-11-12
PCT/US1996/018149 WO1997017988A1 (en) 1995-11-13 1996-11-13 Type ix collagen and chimeras

Publications (2)

Publication Number Publication Date
NO982181D0 NO982181D0 (no) 1998-05-13
NO982181L true NO982181L (no) 1998-07-06

Family

ID=26675846

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982181A NO982181L (no) 1995-11-13 1998-05-13 Type IX collagen og chimerer

Country Status (7)

Country Link
EP (1) EP0861086A1 (de)
JP (1) JP2001510981A (de)
BR (1) BR9611547A (de)
CA (1) CA2237900A1 (de)
IL (1) IL124437A0 (de)
NO (1) NO982181L (de)
WO (1) WO1997017988A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773248A (en) * 1995-11-13 1998-06-30 Uab Research Foundation Nucleic acid encoding a human α3(IX) collagen protein and method of producing the protein recombinantly
AUPO331096A0 (en) * 1996-10-29 1996-11-21 Commonwealth Scientific And Industrial Research Organisation Collagen products
EP0950098B1 (de) * 1996-10-29 2008-09-03 Commonwealth Scientific And Industrial Research Organisation Stabile expression von tripelhelikalen proteinen
AU1593001A (en) * 1999-11-12 2001-06-06 Fibrogen, Inc. Recombinant gelatin in vaccines
AU1770201A (en) * 1999-11-17 2001-05-30 Philadelphia Health & Education Corporation Altered type ix collagen gene sequences associated with intervertebral disc disease
US7268116B2 (en) * 2003-10-02 2007-09-11 Genhunter Corp. Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
CN102212126B (zh) * 2010-04-08 2013-06-19 上海普洛康裕药物研究院有限公司 具有抑制内皮细胞生长活性的重组EDI-8t蛋白
CA2800595C (en) * 2010-05-26 2018-04-24 Shriners Hospitals For Children Compositions comprising the nc2 domain of collagen ix and methods of using same
US11377490B2 (en) 2017-05-31 2022-07-05 Sichuan Clover Biopharmaceuticals, Inc Method for treating cancer using disulfide-linked trimeric 4-1BBL
CN109456989B (zh) * 2018-10-31 2022-03-29 陕西慧康生物科技有限责任公司 一种提高毕赤酵母分泌表达的载体的构建方法
WO2021249116A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus vaccine compositions, methods, and uses thereof
CN112364726B (zh) * 2020-10-27 2024-06-04 重庆大学 基于改进east的零件喷码字符定位的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2143478T5 (es) * 1991-10-23 2006-05-16 Thomas Jefferson University Sintesis de procolagenos y colagenos humanos en sistemas de adn de recombinacion.

Also Published As

Publication number Publication date
JP2001510981A (ja) 2001-08-07
IL124437A0 (en) 1998-12-06
MX9803801A (es) 1998-10-31
NO982181D0 (no) 1998-05-13
WO1997017988A1 (en) 1997-05-22
EP0861086A1 (de) 1998-09-02
BR9611547A (pt) 1999-06-15
CA2237900A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
NO982181L (no) Type IX collagen og chimerer
IS4416A (is) Líkamsþyngdarstillar (modulators), samsvarandi kjarnsýrur og prótein, og notkun þeirra við sjúkdómsgreiningar og í læknismeðhöndlun
ATE358176T1 (de) Menschliche dnase
NL300062I1 (nl) Osteogene middelen.
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
DE69942365D1 (de) Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
ATA260087A (de) Kombination von angiotensin-converting-enzyme- hemmern mit calciumantagonisten sowie ein erzeugnis, das diese enthält, zur anwendung bei der behandlung des bluthochdrucks
NO974824D0 (no) Arteriovenöse og venös transplantasjonsbehandlinger, fremgangsmåter og blandinger
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
ATE196147T1 (de) Wachstumsdifferenzierungsfaktor-12
DE68928728D1 (de) Diagnose von retinoblastoma
DE69721021D1 (de) Blasenmukosa mit zellen für die rekonstruktion von geweben
ATE58638T1 (de) Zusammensetzung und methode zur wiederherstellung von knochen.
MX9203138A (es) Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
ITBO930059A0 (it) Procedimento per ottenere la rigenerazione dei tessuti nella terapia odontoiatrica parodentale.
FI863626A (fi) Dna-sekvenser, rekombinant-dna -molekyler och foerfaranden foer framstaellning av polypeptider som liknar humant lipokortin.
NZ500216A (en) Beta-amyloid peptide-binding proteins and pharmaceutical use
DE69836333D1 (de) Neisseria lactoferrin-bindendes protein
DE69737293D1 (de) Nukleotidsequenz, die für eine flavinmonooxygenase kodiert, das korrespondierende protein, sowie deren verwendungen in diagnostik und therapie
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
DE59814002D1 (de) Sekretion von tragergebundenen proteinen in das periplasma und in den extrazellulären raum
DE68917536D1 (de) Methode zur Reduktion von aromatischen Amino-Gruppen.